Keratosis clinical trials
The registry lists 30 studies for Keratosis across more than 10 countries. 2 are recruiting or about to start. 8 of them are mainly about Keratosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-02. Counting its 8 narrower conditions too, such as Keratosis, Actinic: 506 studies, 61 open.
Get an email when these change. Save the Keratosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (5) · Almirall, S.A. (4) · Graceway Pharmaceuticals, LLC (3) · Sun Yat-sen University (1) · Université du Québec à Trois-Rivières (1) · University Health Network, Toronto (1) · Frankel, Amylynne, M.D. (1) · Biofrontera Bioscience GmbH (1)
What is being tested here
Drugs under test in Keratosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tirbanibulin | 1 | 2 | 3 |
| Imiquimod | 0 | 0 | 3 |
| Topical Tirbanibulin | 0 | 2 | 2 |
| Fluorouracil | 0 | 0 | 1 |
| Ingenol mebutate | 0 | 0 | 1 |
| Nigella sativa | 0 | 0 | 1 |
| Spirulina maxima | 0 | 0 | 1 |
| Allyl sulfide | 0 | 0 | 1 |
Drug classes tested here Antimitotic agents 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 1 Keratosis studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 30 studies, recruiting or not: 20% stop at 75 or younger and 17% at 65; 7% take children; 0% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 30 of 30. search them.
- Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and ForeheadNot yet recruitingNCT07273656Phase 3
- Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid TumorsRecruitingNCT062066811 country
- Identification of Oral Lesions Through an Autofluorescence SystemCompletedNCT05942794Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic KeratosisCompletedNCT06135415Phase 35 countries
- A Study of Tirbanibulin on the Wellbeing of Participants With Actinic KeratosesCompletedNCT05741294Phase 42 countries
- Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and ScalpCompletedNCT05060237Phase 11 country
- Microwave Treatment for Actinic KeratosisActive, not recruitingNCT05636800Not applicable2 countries
- National Registry for Ichthyosis and Related DisordersCompletedNCT000746851 country
- A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar PressuresStatus unknownNCT04336514Not applicable1 country
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpCompletedNCT03285477Phase 31 country
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)CompletedNCT03285490Phase 31 country
- Effectiveness of Saline Water and Lidocaine Injections for the Treatment of Intractable Plantar KeratomaCompletedNCT04777227Not applicable1 country
- Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's DiseaseNo longer availableNCT00535080
- Treatment of Plantar Keratosis With Medicinal Plant in Diabetic PatientsCompletedNCT03447925Phase 21 country
- Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / ResectionWithdrawnNCT02851693Not applicable
- A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its PrecursorsWithdrawnNCT02813902Phase 1
- Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin LesionCompletedNCT03127670Phase 21 country
- Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesStatus unknownNCT019522751 country
- Tobacco Cessation Intervention Study for Oral DiseasesStatus unknownNCT02737176Not applicable1 country
- The Effect of Efudex Treatment on Photoaged SkinCompletedNCT00121511Not applicable1 country
- Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical GelCompletedNCT00239135Phase 21 country
- Effect of Nigella Sativa in the Treatment of Palmer Arsenical KeratosisCompletedNCT01735097Not applicable1 country
- Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical KeratosisCompletedNCT01731756Not applicable1 country
- Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to ArsenicCompletedNCT01752972Not applicable1 country
- Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer KeratosisCompletedNCT01748669Phase 21 country
- Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic KeratosesStatus unknownNCT01229319Phase 41 country
- Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic KeratosisCompletedNCT00116649Phase 41 country
- Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic KeratosesCompletedNCT00110682Phase 41 country
- 1-Year Follow up to the 1473-IMIQ StudyCompletedNCT001140231 country
- Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and HandsCompletedNCT00115154Phase 41 country